Look for any podcast host, guest or anyone
Showing episodes and shows of

Peg Crowley Nowick

Shows

Medical Affairs UnscriptedMedical Affairs UnscriptedThe Intersection between New Product Planning and Medical Affairs with Cathy Symonds, PhDIn this episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD, MBA, Senior Advisor, Medical Affairs Consulting at Lumanity, and Cathy Symonds, PhD, Program Lead and Head of New Product Planning at Arbor Biotechnologies, engage in an insightful discussion about the evolving role of new product planning and its intersection with Medical Affairs. Peg and Cathy explore the strategic importance of new product planning in the lifecycle of medical products, emphasizing how early commercial strategy is essential for successful development and market entry. They discuss various frameworks and best practices, including the creation of a Target Product Profile (TPP), which h...2025-06-2550 minMedical Affairs UnscriptedMedical Affairs UnscriptedRare Insights: Navigating Medical Affairs in Rare Disease Launches with Eva Gallagher, PhD, CNMAPIn the latest episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD and Senior Advisor, Medical Affairs Consulting at Lumanity, engages in a compelling conversation with Eva Gallagher, PhD, CNMAP, VP, Head of Medical Affairs at Agios Pharmaceuticals. They explore the strategic role of Medical Affairs in the rare disease space, discussing best practices for building effective teams, engaging diverse stakeholders, and leveraging digital tools for education. Eva’s journey and success in the field offer a blueprint for how Medical Affairs can drive impactful change and enhance patient outcomes.   The discussion delves into the significance of s...2025-05-2844 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - From Tweets to Trends: Leveraging Social Media for Medical Affairs Insights with Jamie DoggettIn this episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, discusses the critical role of social media listening in healthcare with Jamie Doggett, Associate Director of Social Media Insights and Analytics at Lumanity. They explore the insights obtained from Jamie's whitepaper, Transforming Scientific Conversations: Adapting to a New Era of Healthcare Social Media. Jamie highlights how unprompted online conversations among healthcare professionals and patients can reveal critical insights for pharmaceutical companies. They delve into the usage of platforms like Twitter, Bluesky, and Threads, emphasizing the need for agility in adapting communication st...2025-04-1830 minMedical Affairs UnscriptedMedical Affairs UnscriptedRealizing Value through Effective Medical Affairs Operations with Keith PooleJoin Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, in this episode of Medical Affairs Unscripted as she engages with Keith Poole, Executive Director and Head of Medical Excellence & Impact Enhancement at Merck KGaA, Darmstadt, Germany. They delve into the critical role of Medical Operations in fostering a high-performance culture within organizations. The discussion covers the strategic collaboration between medical operations teams and Medical Directors, focusing on advisory board meetings, strategy, budgeting, and analysis and communication of actionable insights. Furthermore, they examine the qualities of effective leadership in Medical Affairs and outline the steps to build a...2025-03-2745 minMedical Affairs UnscriptedMedical Affairs UnscriptedCreating Synergies by Integrating Across Medical Affairs with Caroline Ojaimi, PhDIn this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, speaks with Caroline Ojaimi, PhD, Head of Global Scientific Communications, Congresses, and External Engagement at Takeda Oncology. Dr. Ojaimi shares her passion for Medical Affairs and provides insights into strategically redesigning organizational structures to enhance agility, efficiency, and cross-functional collaboration. Their discussion covers the importance of dedicated congress leadership, the role of external engagement in shaping scientific communications, and how integrated approaches drive better stakeholder interactions. A key focus of the conversation is the increasing emphasis on...2025-03-0643 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - Use of GenAI in Medical Publications with Tim Becker, PharmD, RPh In this Medical Affairs unscripted Podcast Byte, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, discusses the recently released insights report: Expert Perspectives on the Use of Generative AI in Medical Publication with her colleague, Tim Becker, PharmD, RPh, EVP, Creative Scientific Solutions at Lumanity. Their discussion sheds light on the safe and proper use of Generative AI in medical publications, addressing key concerns such as hallucinations, data privacy, and the need for transparency and accountability. They also explore the future impact of Generative AI on medical communication agencies and their relationships with journals. Although Generative AI can...2025-02-2425 minMedical Affairs UnscriptedMedical Affairs UnscriptedEstablishing Strategic Connections to Accelerate Clinical Trials with Smitha Sivaraman, PhD, MBA In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, engages in an enlightening discussion with Smitha Sivaraman, PhD, MBA, Vice President of Medical Affairs at Verastem Oncology. Their discussion highlights the growing trend of integrating Medical Affairs into the Clinical Development process, and how this integration can streamline development when executed properly. Dr. Sivaraman shares her insights on the expectations for Medical Affairs teams working alongside clinical development, the ideal timing for their involvement, and how their role should progress over time. They also discuss the necessary skills and qualities...2025-01-3142 minMedical Affairs UnscriptedMedical Affairs UnscriptedInsights for Building a Rockstar MSL Team with Cathy Andorfer, PhDIn this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, welcomes Cathy Andorfer, PhD, the national Director of Field Medical for Tourmaline Bio, and author of "The Art of Excellence: Build a Rockstar Career as a Medical Science Liaison and Beyond." Their conversation explores the vital role of medical affairs, emphasizing the importance of strategic vision, continuous learning, and effective communication within the team. Cathy shares her experiences and insights on leadership, stressing the necessity of repetition and clarity in setting objectives. She believes that consistent reminders and clear priorities are...2024-11-2747 minMedical Affairs UnscriptedMedical Affairs UnscriptedGenerative AI Unleashed: Revolutionizing Innovation and Efficiency in Medical Affairs with Jane Carroll, MS, BSN In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, welcomes Jane Carroll, MS, BSN, Vice President of Global Strategy and Operations at Moderna. They discuss the evolving role of medical affairs and the impact of generative AI, specifically ChatGPT, on the field. Jane shares her experiences leveraging AI as a copilot to enhance efficiency and innovation in medical affairs. They delve into the potential of AI to speed up publication processes and reduce biases, ultimately impacting patient care positively. The conversation highlights AI as a tool to augment, not replace...2024-07-2339 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - The Digital Transformation of Medical Affairs with Dan Hennessy, PhD Medical Affairs is going through a digital transformation. What this means, what it will look like, and what value it will bring to pharmaceutical and biotech companies is still unknown. In this third episode of our short form podcast series, we discuss this topic with Dan Hennessy, PhD.  As the Vice President of Medical Affairs at Merus N.V., he has a wealth of Medical Affairs experience and insights. This conversation brings us further along in trying to understand the changes that are coming to the industry, and more specifically how it may affect clinical trial enrollment and engagement.2024-05-2808 minMedical Affairs UnscriptedMedical Affairs UnscriptedThe Value of Medical Affairs – Strategic Thinking and Continuity from Clinical Development to Commercialization and Beyond With Jodi Smith, PhD In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Jodi Smith, PhD, the Global Medical Strategy Lead in Thoracic Oncology at Pfizer, discuss the value of Medical Affairs. While they agree that there’s a cost associated with bringing Medical Affairs into the early development of a drug, they see a clear and measurable benefit, from accelerated enrollment to having a solid foundation for commercialization. Through their many years in different roles within Medical Affairs, they know that to achieve these benefits, organizations need to have the right team mem...2024-04-3045 minMedical Affairs UnscriptedMedical Affairs UnscriptedExcellence in Leadership – International Women’s Day Special With Aree Cheshire, PhD, and Amber Gilbert, MBA Curiosity, empathy, authenticity, strength. Good leaders express many key characteristics and come in all shapes and sizes. In this special International Women’s Day episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, Aree Cheshire, PhD, VP of Client Strategy in UK Communications at Lumanity, and Amber Gilbert, MBA, Global Practice Lead for Value, Access & Outcomes at Lumanity, meet to discuss excellence in leadership. During their conversation they touch on whether good leadership qualities are innate or learned, how to balance being a leader versus a “do-er”, and how to approach leadership differentl...2024-03-0841 minMedical Affairs UnscriptedMedical Affairs UnscriptedThe Patient Impact in Drug Development and Value Demonstration with Len Lichtenfeld, MD, MACP Now, more than ever, the patient voice is being heard by the pharmaceutical industry.  In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Len Lichtenfeld, MD, MACP meet to discuss the ways patients are providing advisement in drug development and valuation.  After hearing about Len’s extensive experience, they delve into the new regulatory changes coming to pharma and biotech that will require the patient experience to be taken into consideration during the drug development process. They conclude by discussing how the patient experience is having an impact on the valuation of new drug...2024-02-2934 minMedical Affairs UnscriptedMedical Affairs UnscriptedThe Role of the MSL in Clinical Trial Enrollment with Dan Hennessy PhD Having a clinical trial that is properly supported and engaged is no easy feat, but accomplishing this can greatly improve the success of your asset. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Dan Hennessy PhD, Vice President of Medical Affairs at Merus N.V., meet for a second time to discuss MSL and stakeholder engagement. They delve more specifically into the key role that Medical Affairs plays in accelerating and improving clinical trial enrollment and highlight how to use MSLs and a Field Medical team in different ways to ensure that yo...2024-02-0136 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - The Digital Transformation of Medical Affairs with Christian Dimaano, PhD, MPH Medical Affairs is going through a digital transformation. What this means, what it will look like, and what value it will bring to pharmaceutical and biotech companies is still unknown. In this third episode of our short form podcast series, we discuss this topic with Christian Dimaano, PhD, MPH.  As the VP, Head of Medical Affairs at Kinnate Biopharma, he has a wealth of Medical Affairs experience and insights. This conversation brings us further along in trying to understand the changes that are coming to the industry.2023-11-1610 minMedical Affairs UnscriptedMedical Affairs UnscriptedUntapped Potential of Social Media Listening in Medical Affairs with Damian EadeSocial media listening is an area with great untapped potential in the pharmaceutical industry. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Damian Eade, Managing Director, Social Analytics, Insight at Lumanity, discuss how a Medical Affairs team approaches social media listening differently than a commercial team. They review the differences between traditional key opinion leaders and digital thought leaders as well as discuss the impact these “digital influencers” have in the social media landscape. They talk through insight collection and learning about the patient experience through social media and how these insights can...2023-10-2738 minMedical Affairs UnscriptedMedical Affairs UnscriptedBuilding US, EU, & Asia PAC Field Medical Teams during Early Development with Christian Dimaano, PhD, MPH A thoughtfully and carefully built Medical Affairs team, and in particular, a Field Medical team can enhance study enrollment and serve as a foundation for future commercialization. In this episode, Peg and Christian Dimaano, PhD, MPH, VP, Head of Medical Affairs at Kinnate Biopharma, discuss the differences between building a Medical Affairs team in the US compared to building teams in the EU or Asia PAC, and the ideal timing for bringing field medical onboard. They review the pros and cons of outsourcing a field team versus building internally and highlight the different skill sets needed for teams at...2023-09-2841 minMedical Affairs UnscriptedMedical Affairs UnscriptedLearning and Development to Propel an Organization Forward with Adeola Davis, PHD, MPA, and Mary Winkles, PharmD An effective learning and development program can be transformative for a Medical Affairs organization. In this discussion, Peg, Adeola Davis, PHD, MPA, Director of Learning Development at Arcadia Pharmaceuticals, and Mary Winkles, PharmD, Global Director, Medical Affairs Training and Capability at Vertex Pharmaceuticals, break down what it takes to build a successful learning and development program and how to measure its success. They highlight when organizations should build a learning and development program and how to think about scalability. Additionally, they discuss how effective and efficient training can greatly increase employee retention as well as help an organization speak...2023-08-3147 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - The Digital Transformation of Medical Affairs with John Yee, MD, MPH Medical Affairs is going through a digital transformation. What this means, what it will look like, and what value it will bring to pharmaceutical and biotech companies is still unknown. In this second episode of our short form podcast series, we discuss this topic with Dr. John Yee.  As the former CMO at Sobi, Dr. Yee has a wealth of Medical Affairs experience and insights. This conversation brings us further along in trying to understand the changes that are coming to the industry.2023-07-2816 minMedical Affairs UnscriptedMedical Affairs UnscriptedWhy PharmDs are a good fit for Medical Affairs with Lumanity Medical Affairs Consulting PharmDs In this special episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD interviews three of Lumanity Medical Affairs Consulting PharmDs, Stephanie Wong, George Shyu, and Chris Maclafferty. They discuss the different paths they took from earning their degree to joining the pharmaceutical industry as well as the additional training and knowledge they felt were required to be successful in Medical Affairs. They breakdown the skills and expertise that PharmDs can bring to a Medical Affairs organization and how they chose to work in a consulting role rather than in a more typical role as a Medical Science Liaison (MSL) or...2023-06-2741 minMedical Affairs UnscriptedMedical Affairs UnscriptedInvesting in Medical Affairs with John Yee, MD, MPH Whether your drug is in an early development phase or in the lifecycle management phase, it is important to know when and how to invest in Medical Affairs. In their discussion this month, Peg and John Yee, MD, MPH and former CMO at Sobi, focus on the value of and the critical need to invest in Medical Affairs. They see Medical Affairs as the “bridge” across all functions and that it sits at the intersection of medicine, science, and business. They highlight the need to communicate and engage with the commercial side of the organization while building a Medical Affa...2023-05-3038 minMedical Affairs UnscriptedMedical Affairs UnscriptedPodcast Bytes - The Digital Transformation of Medical Affairs with Janet Loesberg, PharmD Medical Affairs is going through a digital transformation. What this means, what it will look like, and what value it will bring to pharmaceutical and biotech companies is still unknown. Over the remainder of 2023, we’ll be releasing additional short form podcasts, podcast bytes, where we discuss this topic with our guests. Janet Loesberg, PharmD, SVP of Global Medical Affairs at Blueprint Medicine, is our first guest and we greatly appreciate her insights. We look forward to delving into this topic on future episodes.2023-05-1918 minMedical Affairs UnscriptedMedical Affairs UnscriptedMedical Affairs Leadership – Breaking Through Barriers to Success with Janet Loesberg, PharmD Are you leading or building a Medical Affairs organization? This month Peg had a great conversation with Janet Loesberg where they discussed leadership and the barriers to success in Medical Affairs. Janet Loesberg, PharmD, Senior Vice-President of Global Medical Affairs at Blueprint Medicine, and a biotech board member, brings many years of experience, holding a variety of leadership positions in the pharmaceutical industry. She delivers great advice and perspectives focused on leading in Global and US Medical Affairs, building a team with the right person matched to the right role, and ensuring communication across the team. Dr. Peg Crowley-Nowick...2023-04-2836 minMedical Affairs UnscriptedMedical Affairs UnscriptedDistinguishing between Tracking and Performance Metrics in Medical Affairs with Randy Krauss, PhD Defining metrics and KPIs for demonstration of value is a significant challenge for leaders in Medical Affairs. During this episode of Medical Affairs unscripted, Dr. Crowley-Nowick speaks with Dr. Randy Krauss, Head of Metrics, Analytics, & Performance in Global Clinical Operations at Merck. They discuss the key ideas, lessons learned, and recommendations that have come from Dr. Krauss’s work in clinical operations and how those ideas can be translated into the Medical Affairs space. The objective of this podcast is to stimulate discussion about measurements and value in a more effective way.2023-03-2846 minMedical Affairs UnscriptedMedical Affairs UnscriptedAchieving Global Field Medical Excellence with Robin Winter-Sperry, MD During the latest episode of our Medical Affairs unscripted podcast, Dr. Crowley-Nowick speaks with Dr. Robin Winter-Sperry, Former Global Field Based Medical Lead at Ipsen Biopharmaceuticals. The conversation covers: - What Field Based Medical entails and the roles of Medical Science Liaisons and Field Medical Directors across the globe - What skills are required of field based medical teams today and what the future holds - The unique requirements of those managing a field based medical team - How training can vary significantly across different regions - How to measure the value of f...2023-02-2844 minMedical Affairs UnscriptedMedical Affairs UnscriptedOur Medical Affairs Journey Continues | Zipher becomes Lumanity with Dr. Peg Crowley-NowickDuring this episode of Medical Affairs unscripted, the roles are reversed and Dr. Crowley-Nowick speaks with guest interviewer Dennis Crowley (of The Entrepreneur's Story podcast) about Zipher continuing its journey in Medical Affairs as a part of Lumanity. They discuss Zipher’s history, the acquisition, the integration, and how Zipher, now Lumanity, fits into the larger company structure. Dr. Crowley-Nowick explains how being a part of Lumanity is beneficial to our clients while including some of the new product offerings and capabilities of the expanded team. They reflect on how smoothly and seamlessly the integration has been and discuss so...2023-01-2718 minMedical Affairs UnscriptedMedical Affairs UnscriptedMedical Affairs - Bridging Cross-Functional Partnerships with Holly Schachner, MDDuring this episode of Medical Affairs unscripted, Dr. Crowley-Nowick continues the conversation with Holly Schachner, MD, SVP, Clinical Development at North Sea Therapeutics, discussing how the landscape has changed since they last spoke, two and a half years ago, as the pandemic was just unfolding. They also discuss how Medical Affairs continues to play an integral role in bridging across functions, bringing key stakeholders to the table, so that getting needed therapies to patients remains their central mission.2022-12-0629 minMedical Affairs UnscriptedMedical Affairs UnscriptedField Medical Team Optimization with Christina Tankersley, PharmDWith the pharmaceutical industry becoming more and more heavily competitive, knowing how to conduct an insightful and multidimensional assessment of your Medical Science Liaison (MSL) team to identify gaps and hire the right MSLs to not only accelerate a corporate competitive advantage, but also to cultivate the natural diversity of a proper team for internal peer-to-peer development and external stakeholder rapport is more critical than ever.   With an extensive and influential career in Medical Affairs (MA) at Sanofi Pasteur spanning more than two decades starting in the field and now the current Senior Director of the Field Medical Team i...2022-06-0145 minMedical Affairs UnscriptedMedical Affairs UnscriptedMedical Affairs Capabilities to Create a Competitive Advantage with Tamas Suto, MD, PhDLeading Medical Affairs (MA) organizations have begun to strategically redefine their team’s requisite executional capabilities to enhance and tailor frontline engagement initiatives, to improve the impact of knowledge development (insights and evidence generation), and to further solidify their position as a vital leader rather than a support function within the biopharmaceutical industry. These executional capabilities ultimately accelerate the time to market, creating a competitive advantage as well as (and most importantly) maximizes the number of patients reached with life-saving treatments. Dr. Tamas Suto is passionately dedicated to improving the lives of patients and public health as ev...2022-02-2440 minMedical Affairs UnscriptedMedical Affairs UnscriptedGathering, Understanding, and Leveraging Insights with Muriel Siadak, PACOur host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs and Muriel Siadak, PAC, Senior Medical Director at Seagen Inc., spotlight the ever-increasing value and impact of insights on product strategy, positioning, and tactics. As Medical Affairs (MA) teams are now more than ever asking deeper, multifaceted questions to gain insights about the drivers of patient and healthcare professional decisions, Ms. Siadak, shares her vast experience in MA to help us explore the importance of ensuring that insights are appropriately gathered, disseminated to and discussed with internal stakeholders, and leveraged cross functionally. Contact Zipher at w...2021-11-2334 minMedical Affairs UnscriptedMedical Affairs UnscriptedMedical Affairs Launch Readiness: Building, Planning & Execution with Chris Keir, MD, MSDrs. Crowley-Nowick and Keir set the stage for a successful launch as they consider the key components of a MA Team and their contributions on the road to launch and beyond, from the formation and training of the Medical Science Liaison Team (MSLs) to the early inclusion of Medical Information, to developing best practices for Scientific Communications while also engaging with Patient Advocacy groups as part of the planning process. They also address the importance of a robust Data Generation program with the Medical Director at the helm gaining insights and trends from these data which allows the organization...2021-09-2836 minMedical Affairs UnscriptedMedical Affairs UnscriptedExecuting Launch: Develop, Visualize, and Communicate with John Walsh, MDStarting from the clinical trials and ending with meeting the regulatory demands across various countries, bringing a product to market successfully has become increasingly difficult. Therefore, it is critical that an overall launch strategy is established and executed. Developing an integrated and comprehensive launch roadmap is the first step in preparing for launch. Delivering the Medical Affairs program on time, on target, and on budget is essential for success. A solid program management function and systems ensures that progress is monitored, measured, and communicated and adjustments to the course based on internal and external insights are clearly visible to...2021-07-2834 minMedical Affairs UnscriptedMedical Affairs UnscriptedMeasuring the Impact of Medical Affairs with Meg Heim, RN, MBAMeasuring the impact of the Medical Affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today. There have historically been no simple metrics to evaluate the influence of MA, so our host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs met with Meg Heim, RN, MBA, previously Vice President, Global Head of Scientific Engagement Strategy, Operations and Program Management at Sanofi and currently President at Heim Global Consulting, to discuss a methodology she developed and...2021-05-2628 minMedical Affairs UnscriptedMedical Affairs UnscriptedMedical Affairs as a Strategic Equal and Maximizing a Virtual Launch with Zhen Su, MD, MBAMedical Affairs (MA) continues to shed its historic role as a support function and establish itself as a critical pillar alongside Commercial and Research & Development (R&D). However, shifting from independently, operating functional areas to strategic, cross-functional, business-wide partnerships remains a challenge for MA. Zhen Su, MD, MBA, the current Senior Vice President and Global Head of the Oncology Franchise for Merck KGaA, Darmstadt, Germany offers novel approaches for modernizing perspectives at an individual level regarding the role of MA, by fostering an appreciation and internal mindset of MA as a strategic, partner, while still maintaining the...2021-03-2332 minMedical Affairs UnscriptedMedical Affairs UnscriptedInternal Edition - Building a Comprehensive Data Generation Program with Julie Cahill, MDIn this Internal Edition of the Zipher Medical Affairs Unscripted podcast series, Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs is joined by Zipher’s own Julie Cahill, M.D., Vice President of Consulting and Medical Director Services to continue the conversation from Episode 4: Data Generation • The Intersection Between Medical Affairs and Clinical Development by expanding further on the need to identify data gaps and how organizations can work together to consider the full scope of research that can be used to fill those gaps. Dr. Cahill, an industry expert and a board-certified general surgeon, shares how...2020-10-2017 minMedical Affairs UnscriptedMedical Affairs UnscriptedData Generation - The Intersection Between Medical Affairs and Clinical Development with Adam Schayowitz, PhD, MBAAs the Medical Affairs Unscripted podcast series continues to distinguish Medical Affairs as one of the major pillars of biopharmaceutical organizations, Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs hosts Dr. Adam Schayowitz, an industry veteran and current Vice President and Medicine Team Lead at Pfizer, to discuss the intersection between Medical Affairs (medical) and Clinical Development (development) with regards to data generation as medical continues its evolution as the third pillar in industry. Dr. Crowley-Nowick draws on Dr. Schayowitz’s expertise which crosses both medical and development to get his insight on the potential impact med...2020-09-2946 minMedical Affairs UnscriptedMedical Affairs UnscriptedBuilding an Integrated Engagement Roadmap with Randi Goeckeler, MAZipher’s Medical Affairs unscripted features Randi Goeckeler, an industry expert with over 25 years of experience and most recently the Executive Director of Global Stakeholder Relations at Allergan, who discusses how to build an integrated, strategic stakeholder relations program to accelerate availability of treatments for patients and ultimately help them have better outcomes. Host Peg Crowley-Nowick, Ph.D., MBA, Founder & President of Zipher Medical Affairs invites Randi to share her insights on the challenges that organizations are facing regarding stakeholder relations and how to ensure that engagements are innovative, intentional, interconnected, and impactful. As presented in her St...2020-08-1841 minMedical Affairs UnscriptedMedical Affairs UnscriptedThe Business Objective of Medical Affairs with Holly Schachner, MDDuring this episode of Medical Affairs unscripted, Dr. Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of Medical Affairs (MA) organizations and how MA can move closer to being identified as a strategic pillar within the life sciences industry alongside the Research & Development and Commercial organizations. Dr. Schachner, who has nearly 20 years of experience in the pharmaceutical industry after her work as a clinician and researcher, provides key insights for MA professionals on how to use their position and experience from industry and clinic to...2020-07-2032 minMedical Affairs UnscriptedMedical Affairs UnscriptedStakeholder Engagement with Dan Hennessy, PhD, MBAPeg Crowley, Ph.D., MBA, Founder & President of Zipher Medical Affairs meets with Dan Hennessy, Ph.D., MBA, Vice President of Strategic Excellence at EMD Serono to discuss a fresh look at the complexity of the matrix of stakeholders who play a critical role in the patient care cycle, including the layers of individuals in the clinics and hospitals, in healthcare economy, and in advocacy societies. Drs. Crowley and Hennessy, who combined have about 35 years of experience in industry, address the importance of maintaining scientific exchange between the stakeholders and Medical Affairs organizations during a pandemic, which...2020-05-2140 minThe Entrepreneur\'s StoryThe Entrepreneur's StoryEntrepreneurship: Just What the Doctor OrderedDr. Peg Crowley-Nowick and Dennis Crowley sat down in the offices of Zipher Medical Affairs and discuss how she went from a professor at Harvard Medical School to bootstrapping a thriving medical affairs company.  Hear as they talk about how her experiences from academia helped prepare her to become an entrepreneur, and the many lessons learned from both experiences.  2020-03-0933 min